ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

Cherrie K. Donawho, David J. Frost, Luis E. Rodrı́guez et al.|Clinical Cancer Research|2007

Cited by 770